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OBJECTIVE—Skeletal muscle protein metabolism is resistant
to the anabolic action of insulin in healthy, nondiabetic older
adults. This defect is associated with impaired insulin-induced
vasodilation and mTORC1 signaling. We hypothesized that, in
older subjects, pharmacological restoration of insulin-induced
capillary recruitment would improve the response of muscle
protein synthesis and anabolism to insulin.
RESEARCH DESIGN AND METHODS—Twelve healthy, non-
diabetic older subjects (71  2 years) were randomized to two
groups. Subjects were studied at baseline and during local
infusion in one leg of insulin alone (Control) or insulin plus
sodium nitroprusside (SNP) at variable rate to double leg blood
ﬂow. We measured leg blood ﬂow by dye dilution; muscle
microvascular perfusion with contrast enhanced ultrasound;
Akt/mTORC1 signaling by Western blotting; and muscle protein
synthesis, amino acid, and glucose kinetics using stable isotope
methodologies.
RESULTS—There were no baseline differences between groups.
Blood ﬂow, muscle perfusion, phenylalanine delivery to the leg,
and intracellular availability of phenylalanine increased signiﬁ-
cantly (P  0.05) in SNP only. Akt phosphorylation increased in
both groups but increased more in SNP (P  0.05). Muscle
protein synthesis and net balance (nmol  min
1  100 ml  leg
1)
increased signiﬁcantly (P  0.05) in SNP (synthesis, 43  6t o
129  25; net balance, 16  3t o2 6 12) but not in Control
(synthesis, 41  10 to 53  8; net balance, 17  3t o2  3).
CONCLUSIONS—Pharmacological enhancement of muscle
perfusion and amino acid availability during hyperinsulinemia
improves the muscle protein anabolic effect of insulin in older
adults. Diabetes 59:2764–2771, 2010
R
ecent studies have highlighted that insulin resis-
tance is one of the potential mechanisms under-
lying the involuntary loss of skeletal muscle
mass, strength, and function with aging (sar-
copenia) (1–3). Speciﬁcally, it has been shown that, while
physiological hyperinsulinemia stimulates skeletal muscle
protein synthesis and overall anabolism in young individ-
uals (4–8), in older adults this response is blunted (3,9)
and can be elicited only by unphysiologically high insulin
concentrations (9), or after an acute bout of aerobic
exercise preceding hyperinsulinemia (1). Interestingly,
this age-related insulin resistance of skeletal muscle pro-
teins occurs in nondiabetic older individuals with normal
glucose tolerance and muscle glucose metabolism. The
only other abnormality apparently associated with this
age-related protein anabolic resistance to insulin is endo-
thelial dysfunction. It has been shown that the physiolog-
ical insulin-stimulated increase in endothelial-dependent
vasodilation is blunted in healthy older adults (3,10), and
we recently found that this defect is highly correlated with
the impaired response of muscle proteins to the anabolic
effect of insulin (1,3,9).
Insulin increases muscle perfusion by inducing a
nitric oxide-dependent vasodilation of the precapillary
arterioles in skeletal muscle (11,12). Insulin-induced
vasodilation may or may not be followed by increases in
total blood ﬂow but is accompanied by capillary recruit-
ment resulting in an increased and more homogenous
tissue perfusion (13–15). This mechanism allows for a
greater and more diffuse capillary exchange of sub-
strates and hormones during hyperinsulinemia in skel-
etal muscle. Moreover, we recently found that insulin-
stimulated changes in protein synthesis are dependent
on changes in blood ﬂow and amino acid delivery to the
muscle but not to changes in arterial amino acid con-
centration or insulin concentration (3,7,16). Thus, we
hypothesize that the absence of change in muscle
protein synthesis during hyperinsulinemia in older
adults may be a consequence of unresponsiveness of the
vascular bed to insulin. This, in turn, could hamper the
physiological increase in muscle perfusion and nutrient
ﬂow to the muscle cells and blunt the insulin-stimulated
increase in mammalian target of rapamycin (mTOR)
signaling and muscle protein synthesis.
In this study, the purpose was to determine whether a
restoration of nitric oxide dependent vasodilation during
hyperinsulinemia would increase skeletal muscle protein
synthesis and net balance in older adults. To test this
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leg muscle protein synthesis and net balance to local
insulin infusion alone or with the concomitant infusion of
the nitric oxide donor sodium nitroprusside at variable
rates, to mimic the physiological insulin-induced increase
in blood ﬂow across the leg observed in younger adults
(3,7,16).
RESEARCH DESIGN AND METHODS
Subject characteristics. The study was approved by the Institutional Review
Board of the University of Texas Medical Branch (UTMB) and the Food and
Drug Administration. All subjects gave written, informed consent before
participation in the experiments. Twelve healthy, independent, but sedentary
older volunteers were recruited through the UTMB Claude D. Pepper Older
Americans Independence Center Volunteer Registry (Table 1). Eligibility of
the volunteers was determined by clinical history, a physical examination, and
several laboratory tests including a 2-h, 75-g oral glucose tolerance test. Only
subjects with screening results within normal limits and a stable body weight
for at least three months were included. Subjects were randomly assigned to
a control group receiving insulin alone (Control) or an experimental group
receiving insulin with sodium nitroprusside (SNP). To verify that the older
subjects enrolled in this study were insulin resistant with regards to muscle
perfusion and protein synthesis, data from a group of healthy younger subjects
(n  7, age 32  2 years) undergoing the same insulin infusion protocol as the
Control group are also reported in Fig. 3. The complete dataset for these
younger subjects has been recently published elsewhere (16).
Study design. All subjects were instructed to eat their normal diets and
refrain from strenuous physical activity for the week before participating in
the study. The evening before the study, the subjects were admitted to the
UTMB Clinical Research Center. They were given a standardized dinner (10
kcal/kg of body wt; 60% carbohydrate, 20% fat, and 20% protein) and a snack
at 11:00 P.M., after which they were allowed only water until the end of the
experiment the next day. The next morning, a polyethylene catheter was
inserted into a forearm vein for stable isotope tracer (Isotec Inc., Sigma-
Aldrich, Miamisburg, OH) and dextrose infusion. A retrograde catheter was
placed in the contralateral hand and kept at 60°C to sample arterialized
blood so as to measure systemic insulin and indocyanine green (ICG)
concentrations. Using aseptic procedure and local anesthesia, catheters were
placed retrogradely into the common femoral artery and vein of one leg for
blood sampling. The arterial catheter was also used for the infusion of ICG,
insulin, and sodium nitroprusside (SNP group only). After collecting a back-
ground blood sample, a primed-continuous infusion of L-[ring-
13C6]phenylalanine
(priming dose 2 mol/kg, infusion rate 0.05 mol  kg
1  min
1) and D-[6,6-
2H2]glucose (priming dose 19 mol/kg, infusion rate 0.22 mol  kg
1  min
1)
were started to measure phenylalanine and glucose kinetics (Fig. 1). After 4 h, an
insulin infusion (0.15 mU  min
1  100 ml of leg
1) was started directly into the
femoral artery to increase leg insulin concentrations to postprandial values while
avoiding excessive systemic hyperinsulinemia and consequent hypoaminoaci-
demia (6,7,9). During insulin infusion, arterialized blood glucose concentrations
were measured frequently (every 5–10 min), and 20% dextrose containing 2%
D-[6,6-
2H2]glucose was infused in the forearm catheter at a variable rate to
maintain basal values of arterial blood glucose. To reproduce the insulin-induced
vasodilation observed in young healthy adults (3,7,16), subjects in the SNP group
also received an infusion of sodium nitroprusside administered at variable rate,
starting at 0.01 g  min
1  100 ml of leg
1 (average dose, 0.06  0.01 g  min
1 
100 ml of leg
1), to double leg blood ﬂow as determined by frequent Doppler
ultrasound measurements of the superﬁcial femoral artery (HDI-5000 ultrasound
system, Philips ATL Ultrasound, Andover, MA). Systemic blood pressure was also
frequently monitored during SNP infusion using an arm cuff. At 2.5–3 h (basal)
and 5.5–6 h (insulin infusion), ICG dye (0.5 mg/ml) was infused into the common
femoral artery and four blood samples taken from the common femoral vein and
the hand vein to measure blood ﬂow in the entire leg. After ICG, Perﬂutren Lipid
Microsphere (Deﬁnity, Lantheus Medical Imaging, N. Billerica, MA) was infused
in the wrist vein to measure muscle perfusion of the vastus lateralis, after which
four additional blood samples were obtained from the femoral artery and vein to
measure the concentrations of amino acids, glucose, insulin, and the free
phenylalanine and glucose enrichments. Biopsies of the lateral aspect of the
vastus lateralis muscle of the leg bearing the femoral catheters were taken at 2,
4, 5.5, and 7 h after starting the tracer infusion using aseptic procedure, local
anesthesia, and a 5 mm Bergstro ¨m needle. The ﬁrst two biopsies were taken from
the same incision at a different angle to sample areas at least 5 cm apart. The third
and fourth biopsies were taken from a new incision about 10 cm apart from the
ﬁrst, using the same technique used for the ﬁrst two biopsies. The tissue was
immediately rinsed with ice-cold saline, blotted, frozen in liquid nitrogen, and
stored at 80°C until analyzed. After the fourth biopsy, all infusions were
stopped, the catheters were removed, and the subjects were fed and discharged
after a 2-h observation period.
Analytical methods. Plasma glucose concentrations were measured using an
automated glucose analyzer (Yellow Springs Instrument Co., Yellow Springs,
OH). Insulin concentrations were measured by sandwich enzyme-linked
immunosorbent assay (Linco, St. Charles, MS) using a microplate reader
(Bio-Rad, Hercules, CA). Serum ICG concentrations in the femoral vein and
hand vein were determined spectrophotometrically (Beckman Coulter, Ful-
lerton, CA) at 805, allowing for the calculation of blood ﬂow as previously
described (17,18).
Muscle perfusion was measured at basal and during hyperinsulinemia
using contrast-enhanced ultrasound (CEU) as described by others (19–22).
Brieﬂy, ultrasound imaging of the vastus lateralis muscle was performed in a
transaxial plane 15–20 cm above the patella over the midportion of the
vastus lateralis muscle using a P4-2 phased array transducer. A suspension of
perﬂutren lipid microspheres (Deﬁnity) was infused intravenously (3.5 ml/min
for 8 min) using a mechanical index of 1.3 and a compression of 80%. Once the
systemic microbubble concentrations reached steady state (2 min), back-
ground images were obtained at a frame rate of 1/s. Intermittent imaging was
then performed using an internal timer at pulsing intervals ranging from 1 to
25 s, allowing for progressively greater replenishment of the ultrasound beam
elevation between destructive pulses. Depth, focus, and gain were optimized
at the beginning of each experiment and held constant throughout. Data were
recorded on a magneto optical disk and digitized for analysis using an ofﬂine
system. A minimum of three images were acquired at each pulsing interval.
The background-subtracted video intensity at each pulsing interval was
measured from a region of interest within the vastus lateralis muscle. Pulsing
interval versus video intensity data were curve ﬁtted to the function: y  A(1 –
e
t) where y is the video intensity at pulsing interval t, A is the plateau video
intensity (an index of microvascular blood volume), and  is the rate of
microvascular reﬁlling (an indicator of microvascular ﬂow velocity) (19).
Representative CEU images are shown in Fig. 2.
Free phenylalanine enrichment and
13C6 concentration in blood and tissue
ﬂuid were measured by gas chromatography-mass spectrometry (GCMS, 6,890
Plus GC, 5973N MSD, 7,683 autosampler, Agilent Technologies, Palo Alto, CA)
after addition of an internal standard (L-
15N-phenylalanine), extraction, puri-
ﬁcation, and tert-butyldimethylsilyl derivatization (23).
2H2-glucose enrichment
TABLE 1
Subject characteristics (n  12)
Control SNP
n 6( 5M ,1F ) 6( 4M ,2F )
Age (years) 74  36 9  1
Weight (kg) 74.85  5.18 73.53  6.88
Height (m) 1.68  0.05 1.71  0.05
BMI (kg/m
2) 26.5  2.0 24.8  1.6
Leg volume (ml) 9,489  801 9,122  727
Data are mean  SE.
0  1  2  3  4  5  6  7  Hours 
Blood 
Samples 
Muscle 
Biopsies 
Study 
Period 
CEU  ICG  CEU  ICG 
Variable i.v. Dextrose 
Insulin +/- SNP 
L-[ring-13C6]Phenylalanine, [6,6-2H2]Glucose 
INSULIN  BASAL 
FIG. 1. Study design. Blood and muscle samples are indicated by
arrows. ICG indicates indocyanine green infusion for blood ﬂow mea-
surement. CEU indicates contrast enhanced ultrasound measurement
of muscle perfusion using Deﬁnity microspheres.
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pentaacetate derivatization (23). Muscle tissue samples were mechanically ho-
mogenized, and intracellular free amino acids and muscle proteins were ex-
tracted as described previously (23). The incorporation of labeled phenylalanine
into the mixed muscle proteins was measured by GCMS, after protein hydrolysis
and amino acid extraction, using the external standard curve approach (24).
Muscle tissue samples were also used to measure phosphorylated and total
protein expression of mTOR, Akt/PKB, 4E-BP1, S6K1, ERK1/2, and rpS6. The
primary phospho-antibodies (Cell Signaling, Beverly, MA) used were phospho-
mTOR (Ser 2,448, 1:1,000 in 5% nonfat dairy milk), phospho-Akt (Ser 473, 1:1,000),
phospho-4E-BP1 (Thr 37/46, 1:1,000), phospho-ERK1/2 (Thr202/Tyr204, 1:1,000),
phospho-p70 S6K1 (Thr 389, 1:500), phospho-eEF2 (Thr 56, 1:2000), and phospho-
rpS6 (Ser 235/236, 1:500). A dilution of 1:1,000 was used for total expression of
each protein. Fifty micrograms of total protein homogenate was loaded in
duplicate into each lane, and the samples were separated on a 7.5% or 15%
polyacrylamide gel (150 V, 1 h) (Criterion, Bio-Rad, Hercules, CA), depending
on the size of the target protein. Speciﬁc details of our immunoblotting
technique have been reported elsewhere (25). All samples were normalized to
a rodent internal loading control, and ﬁnal data were reported as phosphor-
ylated protein relative to total protein.
Calculations. The kinetics of intracellular free phenylalanine in response to
exogenous hyperinsulinemia and pharmacological enhancement of muscle
perfusion were calculated using two-pool, three-pool, and precursor-product
models. With the two-pool model, phenylalanine enrichments and concentra-
tions in the femoral artery and vein were measured to estimate muscle protein
synthesis, breakdown, and net balance without any consideration of the
intracellular recycling of amino acids from breakdown to synthesis (26). The
three-pool model also included intracellular amino acid kinetics. A limitation
of this methodology is that the kinetic parameters thus derived are blood ﬂow
dependent. For this reason, we also measured the fractional synthetic rate of
mixed muscle proteins using the precursor-product model (27).
Leg glucose utilization was calculated as the net glucose uptake and
fractional extraction across the leg (23); basal whole-body endogenous
glucose production and utilization were calculated using the single-pool
model (23). During clamp, endogenous glucose production was calculated by
subtracting the exogenous glucose infusion rate from basal whole-body
endogenous glucose production and utilization. Insulin delivery to the leg was
calculated as the product of femoral insulin concentration by blood ﬂow (16).
Details on the calculations, including formulas, are reported in the online
appendix available at http://diabetes.diabetesjournals.org/cgi/content/full/
db10-0415/DC1.
Statistical analyses. Statistical analyses were performed using the statistical
software SigmaStat version 3.5 (Systat Software Inc., San Jose, CA). The
primary end points were measures of blood ﬂow, muscle perfusion, muscle
protein synthesis, and net muscle phenylalanine balance. Secondary end
points were all remaining measures of muscle amino acid turnover, glucose
kinetics, and phosphorylation of intracellular signals. Subjects’ characteristics
were analyzed using one-way ANOVA with the exception of sex, a categorical
variable, which was analyzed using the Fisher exact test. To determine the
effects of vasodilation on the response of muscle protein turnover to insulin in
aging, comparisons were carried out using ANOVA for repeated measures,
with the factors being subject, group (Control, SNP), and time (basal, insulin).
Post hoc comparisons were carried out using the Tukey-Kramer test. For data
that did not pass the normality test, the values were transformed using natural
log (ln) or the reciprocal of the value. All values are listed as means  SEM.
Differences were considered signiﬁcant at P  0.05.
RESULTS
Blood ﬂow, blood pressure, and microvascular perfu-
sion. Basal leg blood ﬂow, systemic blood pressure (Table
2), and microvascular perfusion (Fig. 3) did not differ
between groups. During insulin infusion, blood ﬂow and
microvascular perfusion increased signiﬁcantly only in the
SNP group (P  0.05), with a signiﬁcant difference be-
tween groups (P  0.05). Conversely, systemic blood
pressure did not change signiﬁcantly in either group.
Insulin and glucose kinetics. Insulin and glucose con-
centrations and kinetics are presented in Table 2. There
were no basal differences between the two groups.
During hyperinsulinemic-euglycemic clamp, systemic
and femoral insulin concentrations increased signiﬁ-
cantly in both groups (P  0.05), with no signiﬁcant
differences between groups. Insulin delivery to the leg
increased with insulin infusion in both groups (P  0.05)
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FIG. 2. Representative contrast enhanced ultrasound images of Deﬁnity microsphere infusion into the vastus lateralis of one control and one
SNP subject during the basal period and during insulin infusion with or without concomitant SNP infusion. Each image is captured during the 10-s
pulsing interval.
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Arterial glucose concentration was successfully main-
tained at basal levels in both groups. Leg and whole-
body glucose uptake increased signiﬁcantly (P  0.05)
and endogenous glucose production decreased (P 
0.05) from basal levels in both groups, with no differ-
ences between groups. Leg glucose fractional extraction
increased in both groups with hyperinsulinemia (P 
0.05) and was somewhat higher in the Control group
without reaching statistical signiﬁcance. This was due
to high variability attributable to a single outlier in the
Control group. Statistical analysis performed after ex-
cluding the outlier conﬁrmed the lack of differences
between groups in response to insulin.
Phenylalanine concentrations, enrichments, and ki-
netics. There were no basal differences between the
groups for any concentration, enrichment, and kinetic
parameter (Table 3, Fig. 4). During insulin infusion,
phenylalanine arterial concentrations did not change in
either group. Venous and muscle phenylalanine concen-
trations decreased in both Control and SNP, with no
group differences. Phenylalanine enrichment in the ar-
tery, vein, and muscle increased slightly, yet signiﬁ-
cantly, in both Control and SNP groups (P  0.05) with
no group differences. Phenylalanine delivery to the leg,
output from the leg, net balance, leg rate of disappear-
ance, and utilization for protein synthesis increased
signiﬁcantly in the SNP group only (P  0.05) and were
signiﬁcantly higher than in the Control group during
hyperinsulinemia (P  0.05). Phenylalanine transport
into and out of the muscle increased signiﬁcantly from
the basal level only in the SNP group (P  0.05). Muscle
protein fractional synthetic rate was not different be-
tween groups at baseline but was signiﬁcantly higher in
the SNP group during insulin infusion (Fig. 3B). The leg
phenylalanine rate of appearance did not signiﬁcantly
change in either group. However, phenylalanine release
from proteolysis increased signiﬁcantly in the SNP
group only (P  0.05). Similarly, insulin infusion signif-
icantly increased phenylalanine recycling from protein
breakdown to synthesis (without appearing in circula-
tion) only in the SNP group (P  0.05). Intracellular
phenylalanine availability tended to increase only in the
SNP group as compared with Control (P  0.10).
Cell signaling. Phosphorylation of all measured cell
signals did not differ between groups in the basal state
(Fig. 5). During insulin infusion, Akt/PKB phosphorylation
increased in both groups (P  0.05), but more in SNP (P 
0.05) at the end of the infusion (biopsy 4). Phosphorylation
TABLE 2
Leg blood ﬂow, systemic blood pressure, leg and systemic insulin and glucose concentrations, and kinetics in two groups of healthy
older subjects in the basal state and during local insulin infusion in one leg with (SNP) or without (Control) concomitant infusion
of sodium nitroprusside
Control SNP
Basal Insulin Basal Insulin
Leg blood ﬂow (ml  min
1  100 ml leg
1) 2.6  0.5 3.4  0.6 2.4  0.5 5.6  0.7*
,†
Systemic blood pressure
Systolic (mmHg) 132  4 126  5 128  5 126  6
Diastolic (mmHg) 67  36 7  37 1  56 9  6
Insulin
Systemic concentration (pmol/l) 32  68 7  19* 39  7 101  34*
Femoral vein concentration (pmol/l) 39  8 394  124* 36  7 290  55*
Delivery to the leg (U  min
1  100 ml
leg
1) 15  2 173  20* 15  4 270  50*
,†
Glucose
Arterial concentration (mmol/l) 5.2  0.2 5.3  0.2 5.2  0.1 5.3  0.2
Leg uptake (mol  min
1  100 ml leg
1) 0.4  0.2 3.3  1.5* 0.5  0.1 1.9  0.4*
Leg fractional extraction (%) 3.0  2.5 14.4  7.1*, 3.5  1.1 6.5  1.3*
Endogenous production (mol  kg
1  min
1) 8.6  0.4 6.7  0.4* 9.1  0.2 6.5  0.2*
Whole-body uptake (mol  kg
1  min
1) 8.6  0.4 13.5  0.7* 9.1  0.2 13.7  0.9*
Date are mean  SE. *P  0.05 vs. basal, † indicates group 	 time effect (P  0.05).  values excluding a single outlier: basal 3.7  2.9; insulin
7.4  1.3.
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FIG. 3. Microvascular blood perfusion (A) measured by CEU and
fractional synthetic rate (B) in the basal state and during local insulin
infusion with (SNP) or without (Control) concomitant infusion with
the vasodilator, sodium nitroprusside. To provide normal reference
values, previously published data (16) from a group of younger indi-
viduals (n  7, age  32  2) undergoing the same insulin infusion
protocol as the Control group are also shown. Data are the mean  SE.
*P < 0.05 versus baseline, †P < 0.05 versus Control.
K.L. TIMMERMAN AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 59, NOVEMBER 2010 2767of mTOR and S6K1 increased in both groups (P  0.05)
with no differences between groups. 4E-BP1 phosphoryla-
tion increased with insulin (P  0.05) in both groups with
no differences between groups at mid-infusion (biopsy 3),
but it remained signiﬁcantly elevated only in SNP (P 
0.05) at the end of the infusion (biopsy 4). Phosphorylation
of ERK1/2, eEF2, and rpS6 did not change signiﬁcantly
during hyperinsulinemia in either group (data not shown).
There were no changes in total protein expression for the
measured proteins.
DISCUSSION
This study shows for the ﬁrst time that pharmacologically
increasing blood ﬂow and muscle perfusion during hyper-
insulinemia in older adults enhances muscle protein syn-
thesis and overcomes age-related insulin resistance of
muscle protein anabolism.
Speciﬁcally, local infusion of sodium nitroprusside dur-
ing hyperinsulinemia in our older subjects more than
doubled total leg blood ﬂow, as planned, and induced a
ninefold increase in muscle microvascular perfusion, thus
increasing amino acid delivery to the muscle and stimu-
lating muscle protein synthesis to levels comparable to
those seen during insulin infusion alone in young healthy
subjects (Fig. 3). Conversely, when insulin was infused
alone in a control group, it induced neither vasodilation
nor an increase in amino acid delivery to the leg. Addition-
ally, muscle protein synthesis did not increase, conﬁrming
previous reports by our group and others that the physio-
logical vasodilatory and muscle protein anabolic effect of
insulin observed in young healthy subjects is lost with
aging (3,10). These data provide strong evidence that
insulin’s ability to stimulate blood ﬂow and amino acid
delivery are necessary for it to induce a muscle protein
synthetic response. This interpretation is further corrobo-
rated by our recent ﬁnding that pharmacologic blockade of
insulin-induced vasodilation eliminates the anabolic re-
sponse of muscle to insulin infusion in young subjects (16).
Interestingly, phenylalanine release from muscle protein
breakdown, but not the leg rate of appearance, increased in
the group undergoing pharmacological vasodilation, al-
though to a lesser extent than protein synthesis. As a result,
phenylalanine net balance across the leg switched from
negative to positive, indicating net muscle protein accretion
in the SNP group during hyperinsulinemia. This signiﬁcant
positive effect of vasodilation on net balance indicates that
the increase in muscle protein breakdown was not due to a
modeling artifact or washout effect induced by enhanced
blood ﬂow, because in those instances net balance would
remain negative. Instead, the signiﬁcant change in muscle
protein breakdown appears to be due to acceleration in
intracellular protein turnover, as demonstrated by the signif-
icant increase in phenylalanine intracellular recycling from
breakdown to synthesis. An increase in intracellular amino
acid recycling also occurs in younger subjects during isolated
physiological hyperinsulinemia, as long as amino acid avail-
ability does not decrease (7,28). This may partially explain
the conﬂicting results in the literature of the effects of insulin
on protein synthesis and breakdown. For instance, in con-
trast to data from our laboratory (1,3,7,9,16) and others
(4,6,29–31), hyperinsulinemia has been reported to have no
effect on muscle protein synthesis but to inhibit muscle
protein breakdown (32–36). We believe this discrepancy may
be due to differences in amino acid availability. In studies
reporting an insulin-induced increase in muscle protein syn-
thesis (1,3,4,6,7,9,16,29,30), amino acid delivery increased
due to either exogenous infusion or increased blood ﬂow
with no change in amino acid concentrations, as in the
present study. Conversely, studies showing no increase in
synthesis with decreased breakdown also reported de-
creased or unchanged amino acid availability (32,35,37,38),
mainly due to signiﬁcant reductions in blood amino acid
concentrations induced by systemic hyperinsulinemia.
Blood ﬂow—and, more importantly, muscle perfusion—
emerge as important contributors to the anabolic effect of
insulin on muscle proteins and the age-related insulin
TABLE 3
Leg free phenylalanine concentrations, enrichments, and kinetics in two groups of healthy older subjects at baseline and during local
insulin infusion in one leg with (SNP) or without (Control) concomitant infusion of the vasodilator sodium nitroprusside
Control SNP
Basal Insulin Basal Insulin
Phenylalanine concentration (mol/l)
Femoral artery 63  36 1  46 2  36 3  3
Femoral vein 70  36 2  4* 68  45 9  4*
Muscle 80  10 65  10* 79  46 7  4*
Phenylalanine enrichment (tracer/tracee, %)
Femoral artery 8.9  0.5 9.9  0.2* 9.1  0.4 10.0  0.1*
Femoral vein 6.6  0.4 7.7  0.2* 6.9  0.3 8.4  0.2*
Muscle 5.6  0.2 6.9  0.5* 5.8  0.3 7.2  0.6*
Phenylalanine kinetics (nmol  min
1  100 ml leg
1)
Net balance 17  3 2  3 15  32 6  12*
,†
Delivery to the leg 162  31 196  28 151  31 346  39*
,†
Output from the leg 179  32 198  27 166  34 321  33*
,†
Leg rate of appearance 53  10 54  74 7  96 9  13
Leg rate of disappearance 36  95 2  93 2  69 4  23*
,†
Transport into the muscle 115  28 168  37 103  23 225  46*
Transport out of the muscle 132  28 170  35 118  26 200  38*
Release from proteolysis 58  12 60  85 3  98 1  12*
Utilization for protein synthesis 42  10 58  10 38  6 107  23*
,†
Intracellular availability 173  36 227  40 156  31 307  58*
Recycling 6  26  56  21 3  2*
Data are mean  SE. *P  0.05 vs. basal; † indicates group 	 time effect (P  0.05).
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crovascular perfusion increased insulin delivery to the
muscle and the amount of tissue exposed to insulin.
Insulin has been reported to promote its own transport
across the endothelial barrier to reach its receptor on the
end target tissue, such as skeletal muscle, and this process
may be saturable (39). During this process, insulin also
increases the microvascular surface available for uptake
via endothelial-dependent capillary recruitment (13,40),
thus facilitating its own delivery to the skeletal muscle.
This mechanism may conceivably be lost in older subjects
due to endothelial dysfunction and inability to recruit
capillaries (3,41). Thus, restoring vasodilation and capil-
lary recruitment during hyperinsulinemia in our older
subjects might have led to the observed improvement in
the age-related insulin resistance of muscle protein metab-
olism by augmenting the amount of muscle tissue exposed
to insulin. This explanation is supported by increased
Akt/PKB phosphorylation in the SNP group compared with
the Control group during hyperinsulinemia. Enhanced
Akt/PKB phosphorylation, however, did not result in a
further increase in glucose uptake in the SNP group, which
was somewhat lower, although not signiﬁcantly, than in
the Control group due to an outlier. The relatively modest
improvement in Akt/PKB phosphorylation may have been
insufﬁcient to further activate downstream signals in the
glucose uptake pathway, which were not measured in this
study, or glucose uptake may have already been elevated
in these two groups of healthy, nondiabetic subjects. This
would not be surprising, as we have already shown that
glucose metabolism is more insulin-sensitive than protein
metabolism in healthy nondiabetic subjects (7), as well as
that age-related insulin resistance in muscle protein me-
tabolism does not correlate with the insulin sensitivity of
glucose metabolism (7). However, this explanation is
unlikely to apply under our experimental conditions, be-
cause we used a physiological insulin dose insufﬁcient to
maximally stimulate glucose uptake. A recent theory (42)
suggests, in fact, that increased perfusion enhances only
maximal glucose uptake, when large arteriovenous glu-
cose gradients occur. Conversely, as compared with glu-
cose, amino acids are present in the blood at much lower
concentrations and with larger arteriovenous gradients.
Thus, their uptake may be more sensitive to changes in
blood ﬂow. Lastly, it is also possible that we missed
differences in glucose uptake due to the blood sampling
schedule.
The large SNP-induced increase in blood ﬂow and
microvascular perfusion elevated amino acid transport
into the muscle. However, mTOR phosphorylation at Ser
2,448, which typically responds to changes in amino acid
availability (43), increased in both groups to essentially
the same extent as during hyperinsulinemia. It was re-
cently reported that elevated levels of nitric oxide inhibit
mTOR signaling (44). Because sodium nitroprusside is a
direct nitric oxide donor, the excess nitric oxide produced
by sodium nitroprusside infusion may have blunted the
activation of mTOR in response to elevated amino acid
delivery in the SNP group. Nonetheless, the lack of a group
difference in activation of the mTOR signaling pathway
clearly did not impede an increase in muscle protein
synthesis in the SNP group. As mTOR, S6K1, and 4E-BP1
were equally elevated in both groups during hyperinsulin-
emia, the differences in protein kinetics observed between
SNP and Control subjects may have been due to the
already active translational machinery being exposed to
more amino acids in the SNP group. This interpretation is
supported by previous ﬁndings that amino acid availability
and transport to the muscle appear to modulate the effect
of insulin on muscle protein synthesis and breakdown
(3,6,7,9,16). Finally, we cannot exclude the possibility that
our muscle-sampling schedule, while adequate to detect
changes in protein turnover, was not timed to capture the
largest changes in intracellular signaling under these ex-
perimental conditions.
Overall, these results suggest that pharmacological res-
toration of nitric oxide dependent vasodilation during
hyperinsulinemia can restore the physiological anabolic
response of skeletal muscle proteins to insulin in older
adults. This effect appears mediated by increased availabil-
ity of amino acids to skeletal muscle under hyperinsuline-
mic conditions. Further studies, to examine the effect of
isolated vasodilation on muscle protein turnover, are
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FIG. 4. Phenylalanine delivery to the leg (A), phenylalanine utilization
for protein synthesis (B), and phenylalanine net balance (C) measured
in the basal state and during local insulin infusion with (SNP) or
without (Control) concomitant infusion with the vasodilator, sodium
nitroprusside. Data are the mean  SE. *P < 0.05 versus baseline, †P <
0.05 versus Control.
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encouraging ﬁrst step for future investigations of the
potential use of pharmacological agents to treat sarcope-
nia in older adults, particularly those whose physical
limitations prevent lifestyle interventions, such as exercise
(1,45–47), known to improve muscle function and
metabolism.
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